| Q35120382 | An unusual class of anthracyclines potentiate Gram-positive antibiotics in intrinsically resistant Gram-negative bacteria |
| Q33538688 | Antibacterials - mechanisms of action. |
| Q54440650 | Antisense PNA accumulates in Escherichia coli and mediates a long post-antibiotic effect. |
| Q45378662 | Biomaterials immobilized with chitosan for rechargeable antimicrobial drug delivery |
| Q24678182 | Characterization of the Staphylococcus aureus heat shock, cold shock, stringent, and SOS responses and their effects on log-phase mRNA turnover |
| Q42861000 | Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin |
| Q53834237 | ESKAPEing the labyrinth of antibacterial discovery. |
| Q38887130 | How to Measure Export via Bacterial Multidrug Resistance Efflux Pumps |
| Q33792988 | New developments in the treatment of infective endocarditis infective cardiovasculitis |
| Q47119940 | Predictive compound accumulation rules yield a broad-spectrum antibiotic |
| Q43736410 | Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli |
| Q33635077 | Subcellular Chemical Imaging of Antibiotics in Single Bacteria Using C60-Secondary Ion Mass Spectrometry |
| Q28478754 | Targeting RNA polymerase primary σ70 as a therapeutic strategy against methicillin-resistant Staphylococcus aureus by antisense peptide nucleic acid |
| Q42290322 | Theoretically Guided Analytical Method Development and Validation for the Estimation of Rifampicin in a Mixture of Isoniazid and Pyrazinamide by UV Spectrophotometer |
| Q37335738 | Whole-cell screening-based identification of inhibitors against the intraphagosomal survival of Mycobacterium tuberculosis |
| Q35016160 | Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis? |